Ramananda Madyastha

Title: Innovations in Cancer Diagnosis by Ramananda Madyastha

Introduction

Ramananda Madyastha is an accomplished inventor based in Charleston, SC (US). He has made significant contributions to the field of cancer diagnostics, particularly in the diagnosis of prostate cancer. His innovative approach combines the measurement of specific biomarkers to enhance diagnostic accuracy.

Latest Patents

Madyastha holds a patent for a method titled "Methods for diagnosing cancer by measuring creatine kinase." This diagnostic method provides a way to diagnose prostate cancer by measuring the concentration of prostate-specific antigen and the activity of the creatine kinase enzyme. A mathematical relationship between these two concentrations is established. If the prostate-specific antigen concentration in the blood is normal or near normal, and the creatine kinase enzyme value is lower than normal, there is a high likelihood that the patient has prostate cancer. Additionally, the invention includes measuring the creatine kinase enzyme inhibitor in the serum of a patient to further assess the likelihood of cancer.

Career Highlights

Madyastha is currently associated with Horus Therapeutics, Inc., where he continues to work on innovative solutions in the medical field. His dedication to improving cancer diagnostics has positioned him as a notable figure in the industry.

Collaborations

Some of his coworkers include Zhen Zhang and Stephen D Barnhill, who contribute to the collaborative efforts at Horus Therapeutics, Inc. Their combined expertise enhances the research and development of diagnostic methods.

Conclusion

Ramananda Madyastha's work in cancer diagnostics exemplifies the impact of innovative thinking in medicine. His patented method for diagnosing prostate cancer represents a significant advancement in the field, potentially improving patient outcomes.